← Companies|Bicycle Therapeutics
BC

Bicycle Therapeutics

BCYC·NASDAQCambridge UKFounded 2009300 employees
Small CapbiotechPublicOncology
Platform: Bicycle Toxin
Market Cap
$1.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (BCYC)
Loading BCYC stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
BCY-7343BCY-7343Phase 2/32siRNAGIP-RVEGFiMyelofibrosisHNSCC
BCY-3228BCY-3228Preclinical2PeptideGIP-RCDK2iMeso
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)
2025-06-06
BCY-3228 Interim
Meso
Past
2028-02-05
BCY-3228 Interim
Meso
Interim
2031-03-16
BCY-7343 Ph3 Readout
Myelofibrosis
Ph3 Readout
2031-07-02
BCY-7343 Ph3 Readout
HNSCC
Ph3 Readout